Discover Tenders by Organic Surface Active Agents Sector

Find the most relevant tenders for Organic Surface Active Agents. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Organic Surface Active Agents tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Organic Surface Active Agents tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Haloperidol N05Ad01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3999046

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mesalazine A07Ec02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3998161

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Testosterone G03Ba03 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3997903

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Carbamazepine N03Af01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3995591

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Palonosetron A04Aa05 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3992888

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Schools Outreach Programme

Deadline: 31 Mar 2029

Great Britain

Ref. No.: 3984262

EMD:Ref Document

Bid Value: Ref Document

1208 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 3979420

EMD:Ref Document

Bid Value: Ref Document

550 Days Left

Freesol Broad Agency Annoucement

Deadline: 22 Feb 2029

United States

Ref. No.: 3975293

EMD:Ref Document

Bid Value: Ref Document

1171 Days Left

Schools Outreach Programme

Deadline: 31 Mar 2029

Great Britain

Ref. No.: 3955026

EMD:Ref Document

Bid Value: Ref Document

1208 Days Left

Tri Base Area Construction Basic Ordering Agreement

Deadline: 07 Feb 2029

United States

Ref. No.: 3953654

EMD:Ref Document

Bid Value: Ref Document

1156 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Film Coated Tablets Excluding Potency 2 5Mg As Part Of A So Calle

Deadline: 31 Jan 2026

Germany

Ref. No.: 3943332

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Adalimumab L04Ab04 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940896

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Infliximab L04Ab02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940617

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredient Rivaroxaban B01Af01 With An Effective Strength Of 2 5 Mg Per Divided Dosage Form

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940204

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Hard Capsules Excluding Potency 2 5Mg As Part Of A So Called Open

Deadline: 31 Jan 2026

Germany

Ref. No.: 3939962

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Showing 56476 to 56490 of 56625 results

‹
1
2
...
3763
3764
3765
3766
3767
3768
3769
...
3774
3775
›

Discover Tenders by Organic Surface Active Agents Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Organic Surface Active Agents Sector

Filter Your Search

FREE Trial plan for all new users!